Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Finding a Career after Completing a PhD.

Musrap N.

Clin Chem. 2017 Jun;63(6):1176-1177. doi: 10.1373/clinchem.2016.268813. No abstract available.


Internal Audit of the Canadian Neonatal Network Data Collection System.

Shah PS, Seidlitz W, Chan P, Yeh S, Musrap N, Lee SK; data abstractors of the Canadian Neonatal Network.

Am J Perinatol. 2017 Oct;34(12):1241-1249. doi: 10.1055/s-0037-1603325. Epub 2017 May 12. No abstract available.


Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus.

Hines D, Modi N, Lee SK, Isayama T, Sjörs G, Gagliardi L, Lehtonen L, Vento M, Kusuda S, Bassler D, Mori R, Reichman B, Håkansson S, Darlow BA, Adams M, Rusconi F, San Feliciano L, Lui K, Morisaki N, Musrap N, Shah PS; International Network for Evaluating Outcomes (iNeo) of Neonates.

Acta Paediatr. 2017 Mar;106(3):366-374. doi: 10.1111/apa.13672. Epub 2016 Dec 8. Review.


Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping.

Musrap N, Diamandis EP.

Clin Chem. 2016 Aug;62(8):1066-74. doi: 10.1373/clinchem.2016.256198. Epub 2016 Jun 3. Review.


Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.

Filippou PS, Karagiannis GS, Musrap N, Diamandis EP.

Crit Rev Clin Lab Sci. 2016 Aug;53(4):277-91. doi: 10.3109/10408363.2016.1154643. Epub 2016 May 5. Review.


Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).

Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP.

J Biol Chem. 2015 Jul 10;290(28):17218-27. doi: 10.1074/jbc.M115.639773. Epub 2015 May 24.


Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.

Karagiannis GS, Musrap N, Saraon P, Treacy A, Schaeffer DF, Kirsch R, Riddell RH, Diamandis EP.

Biol Chem. 2015 Feb;396(2):163-83. doi: 10.1515/hsz-2014-0221.


Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.

Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP.

J Proteomics. 2014 May 30;103:204-15. doi: 10.1016/j.jprot.2014.03.042. Epub 2014 Apr 12.


In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.

Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP.

J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.


Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.

Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP.

Mol Oncol. 2014 Mar;8(2):178-95. doi: 10.1016/j.molonc.2013.10.008. Epub 2013 Nov 8.


Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.

Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP.

Mol Cell Proteomics. 2013 Jun;12(6):1589-601. doi: 10.1074/mcp.M112.023887. Epub 2013 Feb 26.


Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.

Kuzmanov U, Musrap N, Kosanam H, Smith CR, Batruch I, Dimitromanolakis A, Diamandis EP.

Clin Chem Lab Med. 2013 Jul;51(7):1467-76. doi: 10.1515/cclm-2012-0642.


Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP.

J Biol Chem. 2012 Oct 5;287(41):34019-31. doi: 10.1074/jbc.M112.384438. Epub 2012 Aug 20.


Revisiting the complexity of the ovarian cancer microenvironment--clinical implications for treatment strategies.

Musrap N, Diamandis EP.

Mol Cancer Res. 2012 Oct;10(10):1254-64. doi: 10.1158/1541-7786.MCR-12-0353. Epub 2012 Aug 15. Review.


Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.

Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP.

Oncotarget. 2012 Mar;3(3):267-85.

Supplemental Content

Loading ...
Support Center